A randomised study of continuous infusional 5-fluorouracil with or without bolus mitomycin-C in patients with advanced colorectal cancer
ISRCTN | ISRCTN27478455 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN27478455 |
Secondary identifying numbers | COMBAT COIRE |
- Submission date
- 19/08/2002
- Registration date
- 19/08/2002
- Last edited
- 30/05/2012
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr - -
Scientific
Scientific
UKCCCR Register Co-ordinator
MRC Clinical Trials Unit
222 Euston Road
London
NW1 2DA
United Kingdom
Study information
Study design | Multicentre randomised controlled trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Hospital |
Study type | Treatment |
Participant information sheet | Not available in web format, please use the contact details below to request a patient information sheet |
Scientific title | |
Study objectives | Not provided at time of registration |
Ethics approval(s) | No ethics approval information required at time of registration. |
Health condition(s) or problem(s) studied | Colon, Rectal cancer |
Intervention | 1. Regimen one: continuous infusion 5-fluorouracil. The infusion will be given for 12 weeks and for a further 12 weeks in responding patients or patients with stable disease. 2. Regimen two: continuous infusion 5-fluorouracil given as above plus mitomycin-C given every 6 weeks for two courses and to a total of four courses in responding patients or patients with stable disease. |
Intervention type | Drug |
Pharmaceutical study type(s) | |
Phase | Not Specified |
Drug / device / biological / vaccine name(s) | 5-fluorouracil, mitomycin-C |
Primary outcome measure | Added 05/08/09: 1. tumour response 2. survival 3. toxicity 4. quality of life (QoL) |
Secondary outcome measures | Not provided at time of registration |
Overall study start date | 13/03/1995 |
Completion date | 13/03/1996 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Not Specified |
Sex | Not Specified |
Target number of participants | 200 (final: 98 active, 97 controls) |
Key inclusion criteria | 1. Histological evidence of metastatic adenocarcinoma of the colon or rectum not amenable to surgery or radiotherapy 2. Patients evaluable for response must have bi-dimensionally measurable disease 3. Patients with no measurable disease 4. Adequate bone marrow function 5. Serum creatinine within normal range 6. Life expectancy of greater than 3 months 7. Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
Key exclusion criteria | 1. History of other malignant disease other than non melanotic skin cancer or carcinoma in situ of the cervix 2. Prior treatment with any cytotoxic agent except adjuvant chemotherapy completed more than 12 months from randomisation 3. Intracerebral metastases or meningeal carcinomatosis 4. Medical contraindications to treatment |
Date of first enrolment | 13/03/1995 |
Date of final enrolment | 13/03/1996 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
UKCCCR Register Co-ordinator
London
NW1 2DA
United Kingdom
NW1 2DA
United Kingdom
Sponsor information
The Royal Marsden NHS Foundation Trust (UK)
Hospital/treatment centre
Hospital/treatment centre
Downs Road
Sutton
SM2 5PT
England
United Kingdom
https://ror.org/0008wzh48 |
Funders
Funder type
Hospital/treatment centre
The Royal Marsden NHS Foundation Trust (UK)
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Study outputs
Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
---|---|---|---|---|---|
Results article | results | 01/10/1997 | Yes | No |